Comparison of sample size formulae for 2 × 2 cross-over designs applied to bioequivalence studies

Pharmaceutical Statistics

Volumn 4, Issue 4, 2005, Pages 233-243

  Siqueira, Arminda Lucia ^a   Whitehead, Anne ^b   Todd, Susan ^b   Lucini, María M ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF READING   (United Kingdom)

Author keywords

Bioequivalence; Cross over; Non central t distribution; Sample size; Two one sided tests

Indexed keywords

DRUG;

AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CALCULATION; CLINICAL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG FORMULATION; INTERMETHOD COMPARISON; METHODOLOGY; NORMAL DISTRIBUTION; OUTCOMES RESEARCH; SAMPLE SIZE; STANDARDIZATION; STATISTICAL ANALYSIS;

EID: 29544433887     PISSN: 15391604     EISSN: None     Source Type: Journal    
DOI: 10.1002/pst.183     Document Type: Article

References (15)

1. Julious SA. Sample sizes for clinical trials with Normal data. Statistics in Medicine 2004; 23: 1921-1986.
2. Schuirmann DJ. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. Journal of Pharmacokinetics and Biopharmaceutics 1987; 15:657-680.
3. Chow S-C, Liu J-P. Design and analysis of bioavailability and bioequivalence studies (2nd edn). Marcel Dekker: New York, 2000.
4. Wellek S. Testing statistical hypotheses of equivalence. Chapman & Hall/CRC: Boca Raton, FL, 2003.
5. Chow S-C, Wang H. On sample size calculations in bioequivalence trials. Journal of Pharmacokinetics and Pharmacodynamics 2001; 28:155-169.
6. Chow S-C, Shao J, Wang H. Sample size calculations in clinical research. Marcel Dekker: New York, 2003.
7. Jones B, Kenward MG. Design and analysis of crossover trials (2nd edn). Chapman & Hall: Boca Raton, FL, 2003.
8. Owen DB. A special case of a bivariate non-central t-distribution. Biometrika 1965; 52:437-446.
9. Diletti E, Hauschke D, Steinjans VW. Sample size determination for bioequivalence assessment by means of confidence intervals. International Journal of Clinical Pharmacology, Therapy and Toxicology 1991; 29:1-8.
10. Siqueira AL, Whitehead A, Todd S, Lucini MM.On sample size calculations for 2 × 2 cross-over designs applied to bioequivalence studies. Technical Report No 04/4, 2004, School of Applied Statistics, University of Reading, UK.
11. Kraemer HC. A central t approximation to the noncentral t. Technical Series No 107, 1978, Laboratory of Stress and Conflict, Dept. of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA.
12. http://www.statsol.ie/nquery/nquery.htm (accessed 27 May 2005).
13. http://www.ncss.com/pass.html (accessed 27 May 2005).
14. http://www.sas.com (accessed 27 May 2005).
15. Wang H, Chow S-C. On statistical power for average bioequivalence testing under replicated crossover design. Journal of Biopharmaceutical Statistics 2002; 12:295-309.